75 related articles for article (PubMed ID: 8972024)
1. Induction of human factor VIII inhibitors in rats 2: Fine mapping of rat anti-human rFVIII antibodies.
Levin LG; Jarvis M; Powell J; Harrison JA; Reisner HM
Thromb Haemost; 1996 Dec; 76(6):998-1003. PubMed ID: 8972024
[TBL] [Abstract][Full Text] [Related]
2. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.
Jarvis MA; Levin LG; Harrison JA; DePianto DJ; Suzuki CM; Ziaja CL; Brown JE; Jolly KW; Reisner HM; Abildgaard CF; Powell JS
Thromb Haemost; 1996 Feb; 75(2):318-25. PubMed ID: 8815584
[TBL] [Abstract][Full Text] [Related]
3. Some factor VIII (FVIII) inhibitors recognise a FVIII epitope(s) that is present only on FVIII-vWF complexes.
Gilles JG; Lavend'homme R; Peerlinck K; Jacquemin MG; Hoylaerts M; Jorieux S; Mazurier C; Vermylen J; Saint-Remy JM
Thromb Haemost; 1999 Jul; 82(1):40-5. PubMed ID: 10456452
[TBL] [Abstract][Full Text] [Related]
4. Human anti-factor VIII antibodies: epitope localization and inhibitory function.
Scandella D
Vox Sang; 1996; 70 Suppl 1():9-14. PubMed ID: 8869462
[TBL] [Abstract][Full Text] [Related]
5. Analysis of factor VIII inhibitors using hybrid human/porcine factor VIII.
Lollar P
Thromb Haemost; 1997 Jul; 78(1):647-51. PubMed ID: 9198232
[TBL] [Abstract][Full Text] [Related]
6. Mapping of FVIII inhibitor epitopes using cellulose-bound synthetic peptide arrays.
Kopecky EM; Greinstetter S; Pabinger I; Buchacher A; Römisch J; Jungbauer A
J Immunol Methods; 2006 Jan; 308(1-2):90-100. PubMed ID: 16376372
[TBL] [Abstract][Full Text] [Related]
7. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
[TBL] [Abstract][Full Text] [Related]
8. Mapping factor VIII inhibitor epitopes using hybrid human/porcine factor VIII molecules.
Lollar P
Haematologica; 2000 Oct; 85(10 Suppl):26-8; discussion 28-30. PubMed ID: 11187866
[TBL] [Abstract][Full Text] [Related]
9. Epitope mapping of polyclonal clotting factor VIII-inhibitory antibodies using phage display.
Mühle C; Schulz-Drost S; Khrenov AV; Saenko EL; Klinge J; Schneider H
Thromb Haemost; 2004 Mar; 91(3):619-25. PubMed ID: 14983240
[TBL] [Abstract][Full Text] [Related]
10. Restricted epitope specificity of anti-FVIII antibodies that appeared during a recent outbreak of inhibitors.
Gilles JG; Peerlinck K; Arnout J; Vermylen J; Saint-Remy JM
Thromb Haemost; 1997 May; 77(5):938-43. PubMed ID: 9184406
[TBL] [Abstract][Full Text] [Related]
11. Immunobiology of inhibitor development in hemophilia A.
Fijnvandraat K; Bril WS; Voorberg J
Semin Thromb Hemost; 2003 Feb; 29(1):61-8. PubMed ID: 12640567
[TBL] [Abstract][Full Text] [Related]
12. Humoral immune responsiveness to a defined epitope on factor VIII before and after B cell ablation with rituximab.
Kessel C; Königs C; Linde R; Escuriola-Ettinghausen C; Stoll H; Klingebiel T; Dietrich U; Kreuz W
Mol Immunol; 2008 Nov; 46(1):8-15. PubMed ID: 18715645
[TBL] [Abstract][Full Text] [Related]
13. Hemophilia treatment. Factor VIII inhibitors with recombinant products: prospective clinical trials.
Lusher JM
Haematologica; 2000 Oct; 85(10 Suppl):2-5; discussion 5-6. PubMed ID: 11187864
[TBL] [Abstract][Full Text] [Related]
14. A soluble recombinant factor VIII fragment containing the A2 domain binds to some human anti-factor VIII antibodies that are not detected by immunoblotting.
Scandella D; Timmons L; Mattingly M; Trabold N; Hoyer LW
Thromb Haemost; 1992 Jun; 67(6):665-71. PubMed ID: 1509407
[TBL] [Abstract][Full Text] [Related]
15. Von Willebrand factor modulates factor VIII immunogenicity: comparative study of different factor VIII concentrates in a haemophilia A mouse model.
Behrmann M; Pasi J; Saint-Remy JM; Kotitschke R; Kloft M
Thromb Haemost; 2002 Aug; 88(2):221-9. PubMed ID: 12195693
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal analysis of factor VIII inhibitors in a previously untreated mild haemophilia A patient with an Arg593-->Cys substitution.
van den Brink EN; Timmermans SM; Turenhout EA; Bank CM; Fijnvandraat K; Voorberg J; Peters M
Thromb Haemost; 1999 May; 81(5):723-6. PubMed ID: 10365744
[TBL] [Abstract][Full Text] [Related]
17. Anti-factor VIII antibodies: a 2005 update.
Lavigne-Lissalde G; Schved JF; Granier C; Villard S
Thromb Haemost; 2005 Oct; 94(4):760-9. PubMed ID: 16270627
[TBL] [Abstract][Full Text] [Related]
18. Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A.
Reipert BM; Ahmad RU; Turecek PL; Schwarz HP
Thromb Haemost; 2000 Nov; 84(5):826-32. PubMed ID: 11127864
[TBL] [Abstract][Full Text] [Related]
19. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
[TBL] [Abstract][Full Text] [Related]
20. Mapping of natural anti-factor VIII antibodies in plasma pools from healthy donors: use of rationally designed synthetic peptides.
Di Giambattista M; Branckaert T; Laub R
Biologicals; 2001; 29(3-4):229-32. PubMed ID: 11851320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
